South Korean pharmaceutical giant Celltrion has started a Phase I clinical trial of an … , Inhalon Biopharma, started administering the drug this month, following a regulatory … health care system, the Korean drugmaker said. THE KOREA HERALD…

… Phathom submitted new drug applications in … and preclinical and clinical testing; regulatory developments … otherwise disrupting its clinical trials, manufacturing and … esophagitis GERD pharmacodynamics medical congress …

Drugmaker Gland Pharma which had entered into an … Reddy's is doing clinical trials now, they are expected to … Sadu, Managing Director of Gland Pharma told analysts at the company … of the second component. Gland Pharma said it is currently focusing …

… of drug trial and thus improve the timeline of clinical trials. The global clinical trial … development, and increasing number of pharmaceutical and biotechnological industries. In addition …

… explains why common psoriasis drugs that block the messenger … skin disease. Clinical trials revealed that newly developed drugs blocking only the … us, because so far drugs for the treatment of … the study Accordingly, psoriasis drugs should only block the …

… of shipments required for these clinical trials. Clinical Trial Supply And Logistics Market Report … firms focused on bringing innovative drugs to the market. Asia Pacific … R & D investment by pharmaceutical and biopharmaceutical firms Market Restraint …

… it comes to clinical trials for tackling conditions … a generalisation that this drug is effective after stroke …  it was essential that clinical trials were representative. Especially as … are intentionally under-represented in clinical trials but, he said, …

… toxicity were observed. The clinical trial design was Open-Label, … adaptive, first-in-human pharmacokinetic (PK), safety, and efficacy … Privo was granted Orphan Drug Designation for Treatment of … efficacy of potent anticancer drugs and significantly improving …

… Artificial Intelligence (AI) Enabled Drug Discovery & Clinical Trials involves collecting information regarding … cost-effective drug discovery is gaining momentum amongst the pharmaceutical industry stakeholders …

Synthetic Biologics, Inc., a diversified clinical-stage company, announced that enrollment has commenced and eight study participants were dosed in the company's phase 1, placebo-controlled, multiple-ascending dose (MAD) clinical study of SYN-020 …